Diabetes risk high in men on anti-HIV meds

	Tweet

The prevalence of Diabetes in HIV-infected men taking antiretroviral drugs is more than four times higher than in HIV-negative men, study suggests.

Today’s powerful anti-HIV drugs—for those who have access to them—have turned HIV into a manageable, chronic disease, said lead investigator Dr. Todd T. Brown. “There can be, however, serious side effects,” said the researcher from Johns Hopkins University, Baltimore.

To investigate how potent combination antiretroviral therapy might affect the likelihood of developing Diabetes, Brown and his colleagues examined data for 710 men free of HIV, 411 HIV-infected men receiving antiretrovirals, and 157 HIV-infected men not being treated with the drugs.

Diabetes Definition
Diabetes is a life-long disease marked by high levels of sugar in the blood. It can be caused by too little insulin (a hormone produced by the pancreas to regulate blood sugar), resistance to insulin, or both.

The team reports in the Annals of Internal Medicine that 57 (14 percent) of the HIV-infected men on antiretroviral combination therapy had Diabetes compared with 33 (5 percent) of the HIV-negative men at the beginning of the study.

After adjusting the data to take account of age and weight, the diabetes rate was 4.6-times higher in HIV-infected men on antiretrovirals and 2.2-times higher in HIV-infected men not taking the drugs, compared to men with HIV.

In those three groups, respectively, diabetes occurred during two years of follow-up at a rate of 4.7, 1.7 and 1.4 cases per 100 persons per year. After adjustment, the rate was 4.11 greater in the men on potent anti-HIV drugs.

“Our study showed that HIV-infected men on these medications had a four-fold greater risk of developing Diabetes compared to a matched HIV-negative population,” Brown said.

Health care professionals, he added, “need to be aware of this potential problem and the possibility of long-term consequences from high blood sugars in HIV-infected patients.”

SOURCE: Annals of Internal Medicine, May 23, 2005.

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]